---
title: 'Commercial Chinese polyherbal preparation Zao Ren An Shen prescription for
  primary insomnia: a systematic review with meta-analysis and trial sequential analysis'
date: '2024-07-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38957383/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240703182124&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Background: Natural products are widely used for primary insomnia (PI).
  This systematic review with trial sequential analysis (TSA) aimed to summarize evidence
  pertaining to the effectiveness and safety of Zao Ren An Shen (ZRAS) prescription,
  a commercial Chinese polyherbal preparation, for treating PI. Methods: Controlled
  clinical trials appraising ZRAS compared to controls or as an add-on treatment were
  systematically searched across seven databases until January 2024. Cochrane ROB
  2.0 ...'
disable_comments: true
---
Background: Natural products are widely used for primary insomnia (PI). This systematic review with trial sequential analysis (TSA) aimed to summarize evidence pertaining to the effectiveness and safety of Zao Ren An Shen (ZRAS) prescription, a commercial Chinese polyherbal preparation, for treating PI. Methods: Controlled clinical trials appraising ZRAS compared to controls or as an add-on treatment were systematically searched across seven databases until January 2024. Cochrane ROB 2.0 ...